Link to this page
National Cancer Institute Thesaurus
Last uploaded:
June 2, 2026
| Id | http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65963
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65963
|
|---|---|
| Preferred Name | Iron Sucrose |
| Definitions |
A sterile aqueous complex of polynuclear iron (III)-hydroxide in sucrose for intravenous use. Following intravenous administration, iron sucrose is dissociated by the reticuloendothelial system into iron and sucrose; the sucrose component is eliminated mainly by urinary excretion. Iron sucrose can be administered with or without erythropoietin to raise hemoglobin levels and may be used in cases of oral iron therapy intolerance or ineffectiveness. Hypersensitivity reactions are less common with iron sucrose compared to other parenteral iron products, such as iron dextran.
|
| Synonyms |
Iron Sucrose Injection
Iron Sucrose
Ferric Hydroxide Sucrose Complex
Saccharated Iron Oxide
iron (III) Oxide, Saccharate
Iron Sucrose for Injection
Saccharated Ferric Oxide
Iron sucrose
Intravenous Ferric Hydroxide Saccharate
Iron Saccharate
Ferric Hydroxide Saccharate Injection
Iron Saccharate Injection
IRON SUCROSE
Venofer
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label | Iron Sucrose
|
|---|---|
| prefixIRI | Thesaurus:C65963
|
| code | C65963
|
| DEFINITION | A sterile aqueous complex of polynuclear iron (III)-hydroxide in sucrose for intravenous use. Following intravenous administration, iron sucrose is dissociated by the reticuloendothelial system into iron and sucrose; the sucrose component is eliminated mainly by urinary excretion. Iron sucrose can be administered with or without erythropoietin to raise hemoglobin levels and may be used in cases of oral iron therapy intolerance or ineffectiveness. Hypersensitivity reactions are less common with iron sucrose compared to other parenteral iron products, such as iron dextran.
|
| Legacy Concept Name | Iron_Sucrose
|
| Contributing_Source |
CTRP
FDA
HemOnc
|
| Accepted_Therapeutic_Use_For | Treatment of iron deficiency for both dialysis and non-dialysis patients with kidney disease, with or without concurrent erythropoietin therapy.
|
| NCI_Drug_Dictionary_ID | 467930
|
| FULL_SYN |
Iron Sucrose Injection
Iron Sucrose
Ferric Hydroxide Sucrose Complex
Saccharated Iron Oxide
iron (III) Oxide, Saccharate
Iron Sucrose for Injection
Saccharated Ferric Oxide
Iron sucrose
Intravenous Ferric Hydroxide Saccharate
Iron Saccharate
Ferric Hydroxide Saccharate Injection
Iron Saccharate Injection
IRON SUCROSE
Venofer
See more
See less
|
| Chemical_Formula | C12H22O11.5Fe.2Na.8O.HO.3H2O
|
| UMLS_CUI | C0060241
|
| FDA_UNII_Code | FZ7NYF5N8L
|
| Preferred_Name | Iron Sucrose
|
| type | |
| subClassOf | |
| Display_Name | Iron Sucrose
|
| CAS_Registry | 8047-67-4
|
| Concept_In_Subset | |
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |